Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers

Summary

The objectives of PROVIDE are to: 1. Determine if prophylactic once weekly hydroxychloroquine reduces the incidence of conversion from SARS-2-CoVnasopharyngeal swab negative to positive 2. To determine if weekly prophylactic hydroxychloroquine reduced the severity of COVID-19 symptoms 3. To determine the safety of taking weekly prophylactic hydroxychloroquine

Timeline

Start

2020-05-01

Primary completion

2020-07-31

Completion

2020-08-30

Outcome

Outcome not reported

Stopped: “Study was not initiated due to evidence becoming available that did not support the use of hydroxychloroquine in this population, with potential risk of added harm”

Drugs

Indications